Literature DB >> 11520825

Bayer faces potential fine over cholesterol lowering drug.

A Tuffs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11520825      PMCID： PMC1121021     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

Review 2.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Withdrawal of cerivastatin from the world market.

Authors:  Curt D Furberg; Bertram Pitt
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

4.  Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities.

Authors:  Venexia M Walker; George Davey Smith; Neil M Davies; Richard M Martin
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.